Search research articles
Contact Us
Filters
Showing results (321-330 of 741) with videos related to
Page
of 75
Sort By:
NPJ Schizophrenia
|
January 23, 2021
Negative symptoms and speech pauses in youths at clinical high risk for psychosis
Emma R Stanislawski, Zarina R Bilgrami, Cansu Sarac, et al.
BJU International
|
December 1, 2012
Re-evaluating the biological significance of seminal vesicle invasion (SVI) in locally advanced prostate cancer
Nikhil Sapre, John Pedersen, Matthew K Hong, et al.
The Psychiatric Quarterly
|
December 10, 1999
Symptom assessment in schizophrenic prodromal states
T J Miller, T H McGlashan, S W Woods, et al.
The American Journal of Psychiatry
|
October 4, 2018
Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications
Antígona Martínez, Pablo A Gaspar, Steven A Hillyard, et al.
Current Cancer Drug Targets
|
April 18, 2015
Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer
Ryan Stuchbery, Natalie J Kurganovs, Patrick J McCoy, et al.
Australian Journal of General Practice
|
November 5, 2024
Updates in digital shared care: Launching into the 21st century
David Homewood, Kevin G Keane, James Haridy, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
January 21, 2018
Prediction of psychosis across protocols and risk cohorts using automated language analysis
Cheryl M Corcoran, Facundo Carrillo, Diego Fernández-Slezak, et al.
Experimental Cell Research
|
July 14, 2009
DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1
Mikael Lerner, Masako Harada, Jakob Lovén, et al.
Nature Immunology
|
March 28, 2006
Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance
Axel Kallies, Edwin D Hawkins, Gabrielle T Belz, et al.
Oncotarget
|
April 28, 2016
Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression
Ryan Stuchbery, Geoff Macintyre, Marek Cmero, et al.
Page
of 75
Search research articles
Search
Showing results (321-330 of 741) with videos related to
Sort By:
Page
of 75
NPJ Schizophrenia
|
January 23, 2021
Negative symptoms and speech pauses in youths at clinical high risk for psychosis
Emma R Stanislawski, Zarina R Bilgrami, Cansu Sarac, et al.
BJU International
|
December 1, 2012
Re-evaluating the biological significance of seminal vesicle invasion (SVI) in locally advanced prostate cancer
Nikhil Sapre, John Pedersen, Matthew K Hong, et al.
The Psychiatric Quarterly
|
December 10, 1999
Symptom assessment in schizophrenic prodromal states
T J Miller, T H McGlashan, S W Woods, et al.
The American Journal of Psychiatry
|
October 4, 2018
Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications
Antígona Martínez, Pablo A Gaspar, Steven A Hillyard, et al.
Current Cancer Drug Targets
|
April 18, 2015
Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer
Ryan Stuchbery, Natalie J Kurganovs, Patrick J McCoy, et al.
Australian Journal of General Practice
|
November 5, 2024
Updates in digital shared care: Launching into the 21st century
David Homewood, Kevin G Keane, James Haridy, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
January 21, 2018
Prediction of psychosis across protocols and risk cohorts using automated language analysis
Cheryl M Corcoran, Facundo Carrillo, Diego Fernández-Slezak, et al.
Experimental Cell Research
|
July 14, 2009
DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1
Mikael Lerner, Masako Harada, Jakob Lovén, et al.
Nature Immunology
|
March 28, 2006
Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance
Axel Kallies, Edwin D Hawkins, Gabrielle T Belz, et al.
Oncotarget
|
April 28, 2016
Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression
Ryan Stuchbery, Geoff Macintyre, Marek Cmero, et al.
Page
of 75